BuzzStocksBoards.com

Shares of CEL-SCI Corporation (AMEX: CVM) jumped more than 24 percent in morning trading Monday after the company announced plans to move forward with two highly-anticipated drug trials.

In addition to recent FDA approval to go ahead with clinical trials of CEL-SCI’s novel LEAPS-H1N1 flu medication, the company has also raised the capital necessary to go forward with Phase III clinical trials of its flagship cancer treatment, Multikine, which analysts believe could become a standard ...

Shares of communication products maker, Zoom Technologies, Inc. (NASDAQ: ZOOM) were up as much as 140 percent in morning trading Monday from after the company announced second quarter financials for Gold Lion Holdings, a leading Chinese mobile phone manufacturer that Zoom acquired earlier this month.

For the second quarter of 2009, Gold Lion more than tripled its revenues to $53.1 million, compared to the same period last year. Furthermore, second quarter revenues were up 84 ...

Shares of Opexa Therapeutics, Inc. (NASDAQ: OPXA) were up more than 150 percent from Friday’s close in morning trading on Tuesday, after the company announced that more than 83 percent of patients taking its experimental multiple sclerosis drug, Tovaxin, remained relapse-free after one-year.

In addition, the annualized relapse rate among patients who took Tovaxin fell to 20 percent, a 42 percent reduction compared with the placebo. Tovaxin also showed stabilization and improvement of MS-related disabilities ...

Shares if the biopharmaceutical corporation The Medicines Company (NASDAQ: MDCO) skyrocketed 30 percent Wednesday morning after the company announced The United States Patent and Trademark Office (PTO) had issued a new patent for Angiomax, an anti-clotting drug for patients undergoing coronary angioplasty.

In clinical trials, Angiomax showed absolute reduction of 1.7 percent in cardiac mortality and improved overall survival in patients who had suffered the most severe form of heart attack and received angioplasty. The ...

Shares of biopharmaceutical company Icagen, Inc. (NASDAQ: ICGN) were up as much as 65 percent from Monday’s close in morning trading on Tuesday, after the company announced favorable results from a late-stage clinical trial of Senicapoc, a potential new treatment for asthma.

"We are pleased with the results of this study, and believe that they justify further evaluation of Senicapoc as a novel approach to the treatment of asthma," said Seth Hetherington, M.D., Senior Vice ...

This is the official Buzz Board thread for Pennichuck Corporation (PNNW). Feel free to post comments, rants or questions about the company here.

This is the official Buzz Board thread for Pennantpark Investment Corporation (PNNT). Feel free to post comments, rants or questions about the company here.

This is the official Buzz Board thread for Penn National Gaming, Inc. (PENN). Feel free to post comments, rants or questions about the company here.

This is the official Buzz Board thread for Penford Corporation (PENX). Feel free to post comments, rants or questions about the company here.

This is the official Buzz Board thread for Pegasystems Inc. (PEGA). Feel free to post comments, rants or questions about the company here.